Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 471871202 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Velan Capital Investment Management LP
13G
|
9.9% |
8/17/2026
Event 8/17/2026
|
||
| Velan Capital Master Fund LP | 8.9% | |||
| Velan Capital Holdings LLC | 8.9% | |||
| Velan Horizon Fund LP | 0.2% | |||
| Velan Horizon GP LLC | 0.2% | |||
| Avego Healthcare Capital, L.P. | 0.7% | |||
| Avego Healthcare Capital Holdings, LLC | 0.7% | |||
| Avego Management LLC | 0.7% | |||
| Velan Capital Investment Management LP | 9.9% | |||
| Velan Capital Management LLC | 9.9% | |||
| Morgan Adam | 9.9% | |||
| Venkataraman Balaji | 9.9% | |||
| Kapoor Vishal | 0.1% | |||
| T. Rowe Price Investment Management, Inc. 13G | 7.1% |
11/14/2025
Event 9/30/2025
|
||
|
Acorn Bioventures, L.P.
13G/A
|
5.3% |
1/26/2026
Event 1/23/2026
|
||
| Acorn Bioventures, L.P. | 2.2% | |||
| Acorn Capital Advisors GP, LLC | 2.2% | |||
| Acorn Bioventures 2, L.P. | 3.1% | |||
| Acorn Capital Advisors GP 2, LLC | 3.1% | |||
| Anders Hove | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (8) | ||||
|
Morgan Stanley
13G/A
|
4.8% |
5/12/2026
Event 3/31/2026
|
||
| Morgan Stanley | 4.8% | |||
| Morgan Stanley Capital Services LLC | 4.6% | |||
|
Kingdon Capital Management, L.L.C.
13G/A
|
4.7% |
11/12/2025
Event 9/30/2025
|
||
| Kingdon Capital Management, L.L.C. | 4.7% | |||
| Mark Kingdon | 4.7% | |||
|
Carlyle Group Inc.
13D/A
|
3.8% |
2/18/2026
Event 2/18/2026
|
||
| The Carlyle Group Inc. | 3.8% | |||
| Carlyle Holdings I GP Inc. | 3.8% | |||
| Carlyle Holdings I GP Sub L.L.C. | 3.8% | |||
| Carlyle Holdings I L.P. | 3.8% | |||
| CG Subsidiary Holdings L.L.C. | 3.8% | |||
| TC Group, L.L.C. | 3.8% | |||
| Carlyle Investment Management L.L.C. | 3.8% | |||
| Carlyle Genesis UK LLC | 3.8% | |||
| Abingworth LLP | 3.8% | |||
| Abingworth Bioventures VII LP | 3.8% | |||
|
Qiming U.S. Healthcare Fund II, L.P.
13G/A
|
3.3% |
11/14/2025
Event 9/30/2025
|
||
| Qiming U.S. Healthcare Fund II, L.P. | 3.3% | |||
| Qiming U.S. Healthcare GP II, LLC | 3.3% | |||
| Mark McDade | 3.3% | |||
| Gary E Rieschel | 3.3% | |||
|
Integrated Core Strategies (US) LLC
13G/A
|
1.7% |
7/10/2026
Event 6/30/2026
|
||
| Integrated Core Strategies (US) LLC | 1.7% | |||
| Millennium Management LLC | 1.7% | |||
| Millennium Group Management LLC | 1.7% | |||
| Israel A. Englander | 1.7% | |||
| BlackRock, Inc. 13G/A | 1.5% |
7/17/2025
Event 6/30/2025
|
||
|
Soleus Capital Master Fund, L.P.
13G/A
|
1.0% |
5/8/2026
Event 3/31/2026
|
||
| Soleus Capital Master Fund, L.P. | 0.4% | |||
| Soleus Private Equity Fund III, L.P. | 0.6% | |||
| Soleus Private Equity GP III, LLC | 0.6% | |||
| Soleus PE GP III, LLC | 0.6% | |||
| Soleus Capital, LLC | 0.4% | |||
| Soleus Capital Group, LLC | 0.4% | |||
| Soleus Capital Management, L.P. | 1.0% | |||
| Soleus GP, LLC | 1.0% | |||
| Guy Levy | 1.0% | |||
|
Goldman Sachs Group Inc
13G/A
|
0.5% |
5/8/2026
Event 3/31/2026
|
||
| The Goldman Sachs Group, Inc. | 0.5% | |||
| Goldman Sachs & Co. LLC | 0.5% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 49 | 12.0 M | $5.05 M |
| 2026 Q1 | 61 | 15.8 M | $13.9 M |
| 2025 Q4 | 61 | 19.6 M | $35.9 M |
| 2025 Q3 | 65 | 20.2 M | $47.8 M |
| 2025 Q2 | 70 | 12.5 M | $69.6 M |
| 2025 Q1 | 73 | 13.0 M | $56.1 M |
| 2024 Q4 | 99 | 15.7 M | $335 M |
| 2024 Q3 | 89 | 14.7 M | $275 M |
| 2024 Q2 | 76 | 14.9 M | $337 M |
| 2024 Q1 | 69 | 13.4 M | $391 M |
| 2023 Q4 | 1 | 495 k | $390 k |